OSI Pharmaceuticals, an ANCO Corporate Member, is supporting Tailoring the Treatment of Non-Small Cell Lung Cancer (NSCLC): From the Surgeon to the Oncologist, a CME-accredited meeting series that will bring faculty (one oncologist and one surgeon) to your practice for a breakfast, lunch, or dinner presentation.
To take advantage of this unique educational opportunity, please contact rpilotti@curryrockefellergroup.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment